Around 60 children and young people each year will benefit from Pedmarqsi.

Evening Standard

London

Greater London

England

United Kingdom

NHS to get drug which helps prevent hearing loss in children having chemotherapy

Ad Fontes Media

All Sides

Media Bias/Fact Check

The Independent

Evgeny Lebedev

Shropshire Star

MNA Media

Ketley

Shropshire

Alfred Harmsworth (barrister)

Geraldine Mary Harmsworth

Patricia Harmsworth, Viscountess Rothermere

Carron Greig

The chemotherapy drug cisplatin is widely used to treat many cancers, especially in children, but around 60% of children treated with cisplatin experience permanent hearing loss

Chronicle Live

Reach plc

Newcastle upon Tyne

Tyne and Wear

"Groundbreaking" new drug to be available on NHS to help prevent hearing loss

Groundbreaking therapy shows 50% reduction in cisplatin-induced hearing loss in children. Major NHS approval follows $43M Norgine licensing deal with potential $230M milestone payments.

stocktitan.net

Fennec's PEDMARQSI® Breakthrough: First NHS Treatment for Child Cancer-Related Hearing Loss

Your support helps us to tell the story 
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it’s investigating the financials of Elon Musk’s pro-Trump PAC or producing our latest documentary, ‘The A Word’, which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging. At such a critical …

elrisala.com

Around 60 children and young people each year will benefit from Pedmarqsi.  A “groundbreaking” drug which helps to prevent hearing loss among children undergoing cancer treatment has been given the green light for NHS use. Chemotherapy drug cisplatin is widely used to treat many cancers, especially in children. But experts have said that around 60% of children treated with cisplatin experience permanent hearing loss as the drug builds up in the …

perspectivemedia.com

NICE has recommended a treatment to prevent and reduce hearing loss in babies, children and teenagers being treated for cancer.

Nursing Times

Children receiving chemo set to benefit from hearing loss treatment

WHITE BEAR LAKE, MINNESOTA – Envoy Medical®, Inc. (NASDAQ: “COCH”), a hearing health company dedicated to developing innovative solutions for hearing loss, announced the issuance of four new patents. The U.S. Patent & Trademark Office issued Envoy Medical Corporation U.S. Patent No. 12,151,102 on November 25, 2024. Titled Combination Hearing Aid and Cochlear Implant System, the patent focuses on updating a transfer function within the implanted …

hearinghealthmatters.org

Envoy Medical Expands Patent Portfolio to Advance Hearing Loss Solutions | Hearing Health & Technology Matters

Climate Change

NHS to get drug which helps prevent hearing loss in children having chemotherapy

Coverage Details

Give the gift of Perspective

Bias Distribution

Ownership

Similar News Topics

Similar News Topics